Cannabinoids Without the Cannabis
Producing cannabinoids via enzymatic biosynthesis could avoid “the vagaries of plant extraction,” say researchers
Preparing for the Next Pandemic
The Medicine Maker catches up with Russell Basser, from Seqirus to discuss the past, present, and future of vaccine production.
Curing Cancer? That’s Cute
The Medicine Maker
From the fringe of the fringe to a revolution in medicine; this is the cell and gene therapy story
A Deep Dive Into Cannabinoid Pharmacology
Cannabinoid pioneer Roger Pertwee shares his highlights from 50 years of ground-breaking research
Exclusive interview with CRUK about a clinical trial set up for a Covid-19 antiviral
Earlier this year, Cancer Research UK announced it was taking part in a clinical trial to investigate whether a drug, typically used to treat pancreatitis in Japan and South Korea, could be used as an antiviral to treat Covid-19…
Oncology collaboration for the UK
Led by Bruntwood SciTech with funding from Innovate UK and Cancer Research UK, the Oncology Development Programme at Alderley Park is aiming to develop an entrepreneurial culture amongst cancer researchers in the UK…
How Do Cancer Cells Spread?
Breakthrough research from Johns Hopkins Medicine has revealed new insight into how cancer cells spread, with the findings published in the journal Cancer Research…
Collaboration to Develop Tumour Progression Regulator Leads
UK-based biopharmaceutical company Phoremost and AI driven pharmatech XtalPi, have signed an agreement to identify and develop compounds to advance a drug discovery program against targets that epigenetically regulate tumour…
New Chair Announced by ELRIG
Melanie Leveridge has been elected as Chair of the European Laboratory Research & Innovation Group (ELRIG), a not-for-profit organisation helping to drive collaboration and knowledge exchange between academic and biopharma…
Respiratory Diseases Portfolio Acquired for Development
Biopharmaceutical company Enterprise Therapeutics, a developer of therapies for respiratory disease, has announced that its TMEM16A potentiator portfolio has been fully acquired by Roche and will be developed by…
Indian Pharma: A Blossoming Market
The Medicine Maker
India is emerging as an economic powerhouse, but what opportunities and barriers does the country’s pharma industry face?
Why (Cannabis) Scientists Should be CEOs
Too many cannabis start-ups are stuck in a rut – to truly innovate, we need technical expertise at the top…
Pharma firms found guilty in supply of life-saving drug to NHS
Three pharmaceutical companies conducted illegal activity into the supply of a life-saving medicine, an investigation has found.
Researchers identify biomarker which could help dementia treatments
Researchers in the UK and Australia have identified a new biomarker which could support the development of new treatments for dementia.
BMA urges government to continue routine vaccinations
The British Medical Association (BMA) has urged the government to ensure routine vaccinations continue after coverage has fallen in recent years and during the Covid-19 pandemic.
Coronavirus Trials to Assess new Method of Vaccine Delivery
Researchers at Imperial College London (ICL) are set to begin trials on two of the UK’s coronavirus vaccines being developed by ICL and Oxford University, which are based on direct inhalation.
Merck Announces €59 Million Antibody-Drug Conjugate Manufacturing Expansion
Merck has announced a €59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA. This investment will allow large-scale manufacturing…
Beximco Pharma and Serum Institute of India Announce COVID-19 Vaccine Cooperation
Beximco Pharmaceuticals Ltd, the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, and the Serum Institute of India Pvt Ltd (SII), the world’s largest vaccine producer, today announce…
Rethinking oncological drug discovery with advances in analytical proteomics technology
Despite advances in genomics, some aspects of cell behaviour can only be understood by exploring proteins. Cell signalling pathways, which commonly rely upon protein ‘receptors’ binding to signalling molecules…
Solving Freeze Drying Bottlenecks For Diagnosticsand Vaccines Production In The ‘New Normal’
The Covid-19 pandemic has largely been characterised by speed; the speed at which the virus spread, the exponential increase in affected patients, the overload of healthcare systems and even the…
Why Have Scientists Created a COVID-19 Replica?
In the latest attempt to understand the novel coronavirus, researchers at Washington University School of Medicine in St. Louis have created a lab-made version that imitates the infection path and…